These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 35163706)

  • 41. Microglial lysophosphatidic acid promotes glioblastoma proliferation and migration via LPA
    Amaral RF; Geraldo LHM; Einicker-Lamas M; E Spohr TCLS; Mendes F; Lima FRS
    J Neurochem; 2021 Feb; 156(4):499-512. PubMed ID: 32438456
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tumor associated CD70 expression is involved in promoting tumor migration and macrophage infiltration in GBM.
    Ge H; Mu L; Jin L; Yang C; Chang YE; Long Y; DeLeon G; Deleyrolle L; Mitchell DA; Kubilis PS; Lu D; Qi J; Gu Y; Lin Z; Huang J
    Int J Cancer; 2017 Oct; 141(7):1434-1444. PubMed ID: 28612394
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mir-370-3p Impairs Glioblastoma Stem-Like Cell Malignancy Regulating a Complex Interplay between HMGA2/HIF1A and the Oncogenic Long Non-Coding RNA (lncRNA) NEAT1.
    Lulli V; Buccarelli M; Ilari R; Castellani G; De Dominicis C; Di Giamberardino A; D Alessandris QG; Giannetti S; Martini M; Stumpo V; Boe A; De Luca G; Biffoni M; Marziali G; Pallini R; Ricci-Vitiani L
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32443824
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Friends with Benefits: Chemokines, Glioblastoma-Associated Microglia/Macrophages, and Tumor Microenvironment.
    Codrici E; Popescu ID; Tanase C; Enciu AM
    Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269652
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tumor microenvironment tenascin-C promotes glioblastoma invasion and negatively regulates tumor proliferation.
    Xia S; Lal B; Tung B; Wang S; Goodwin CR; Laterra J
    Neuro Oncol; 2016 Apr; 18(4):507-17. PubMed ID: 26320116
    [TBL] [Abstract][Full Text] [Related]  

  • 46. γ-Glutamyl transferase 7 is a novel regulator of glioblastoma growth.
    Bui TT; Nitta RT; Kahn SA; Razavi SM; Agarwal M; Aujla P; Gholamin S; Recht L; Li G
    BMC Cancer; 2015 Apr; 15():225. PubMed ID: 25884624
    [TBL] [Abstract][Full Text] [Related]  

  • 47. High expression of RFX4 is associated with tumor progression and poor prognosis in patients with glioblastoma.
    Jeong HY; Kim HJ; Kim CE; Lee S; Choi MC; Kim SH
    Int J Neurosci; 2021 Jan; 131(1):7-14. PubMed ID: 32075484
    [No Abstract]   [Full Text] [Related]  

  • 48. The Critical Role of Proteolytic Relay through Cathepsins B and E in the Phenotypic Change of Microglia/Macrophage.
    Ni J; Wu Z; Peterts C; Yamamoto K; Qing H; Nakanishi H
    J Neurosci; 2015 Sep; 35(36):12488-501. PubMed ID: 26354916
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Glioblastoma-derived extracellular vesicles modify the phenotype of monocytic cells.
    de Vrij J; Maas SL; Kwappenberg KM; Schnoor R; Kleijn A; Dekker L; Luider TM; de Witte LD; Litjens M; van Strien ME; Hol EM; Kroonen J; Robe PA; Lamfers ML; Schilham MW; Broekman ML
    Int J Cancer; 2015 Oct; 137(7):1630-42. PubMed ID: 25802036
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Astrocytes and the tumor microenvironment inflammatory state dictate the killing of glioblastoma cells by Smac mimetic compounds.
    Malone K; Dugas M; Earl N; Alain T; LaCasse EC; Beug ST
    Cell Death Dis; 2024 Aug; 15(8):592. PubMed ID: 39147758
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cystatin F acts as a mediator of immune suppression in glioblastoma.
    Senjor E; Perišić Nanut M; Breznik B; Mitrović A; Mlakar J; Rotter A; Porčnik A; Lah Turnšek T; Kos J
    Cell Oncol (Dordr); 2021 Oct; 44(5):1051-1063. PubMed ID: 34189679
    [TBL] [Abstract][Full Text] [Related]  

  • 52. AHIF promotes glioblastoma progression and radioresistance via exosomes.
    Dai X; Liao K; Zhuang Z; Chen B; Zhou Z; Zhou S; Lin G; Zhang F; Lin Y; Miao Y; Li Z; Huang R; Qiu Y; Lin R
    Int J Oncol; 2019 Jan; 54(1):261-270. PubMed ID: 30387845
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Increased microglia/macrophage gene expression in a subset of adult and pediatric astrocytomas.
    Engler JR; Robinson AE; Smirnov I; Hodgson JG; Berger MS; Gupta N; James CD; Molinaro A; Phillips JJ
    PLoS One; 2012; 7(8):e43339. PubMed ID: 22937035
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Phospho-mTOR expression in human glioblastoma microglia-macrophage cells.
    Lisi L; Ciotti GMP; Chiavari M; Pizzoferrato M; Mangiola A; Kalinin S; Feinstein DL; Navarra P
    Neurochem Int; 2019 Oct; 129():104485. PubMed ID: 31195027
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The Heterogeneity of Tumour-Associated Macrophages Contributes to the Recurrence and Outcomes of Glioblastoma Patients.
    Xuan Z; Fang L; Zhang G; Zhang X; Jiang J; Wang K; Huang P
    J Mol Neurosci; 2023 Jan; 73(1):1-14. PubMed ID: 36542317
    [TBL] [Abstract][Full Text] [Related]  

  • 56. An miR-340-5p-macrophage feedback loop modulates the progression and tumor microenvironment of glioblastoma multiforme.
    Liu Y; Li X; Zhang Y; Wang H; Rong X; Peng J; He L; Peng Y
    Oncogene; 2019 Dec; 38(49):7399-7415. PubMed ID: 31427735
    [TBL] [Abstract][Full Text] [Related]  

  • 57. CD44 attenuates activation of the hippo signaling pathway and is a prime therapeutic target for glioblastoma.
    Xu Y; Stamenkovic I; Yu Q
    Cancer Res; 2010 Mar; 70(6):2455-64. PubMed ID: 20197461
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A Heterotypic Tridimensional Model to Study the Interaction of Macrophages and Glioblastoma In Vitro.
    Gattas MJ; Estecho IG; Lago Huvelle MA; Errasti AE; Carrera Silva EA; Simian M
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34065977
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Local Targeting of NAD
    Li M; Kirtane AR; Kiyokawa J; Nagashima H; Lopes A; Tirmizi ZA; Lee CK; Traverso G; Cahill DP; Wakimoto H
    Cancer Res; 2020 Nov; 80(22):5024-5034. PubMed ID: 32998997
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A HIF-independent, CD133-mediated mechanism of cisplatin resistance in glioblastoma cells.
    Ahmed EM; Bandopadhyay G; Coyle B; Grabowska A
    Cell Oncol (Dordr); 2018 Jun; 41(3):319-328. PubMed ID: 29492900
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.